Dopexamine

CARDIOVASCULAR SYSTEM

Key facts

Dopexamine is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1989. DrugCentral lists 2 molecular targets, including ADRB2 and DRD1.

• Molecular targets: ADRB2 and DRD1 (2 listed in DrugCentral).
• ATC code: C01CA14 (Adrenergic and dopaminergic agents).
• Molecular formula: C22H32N2O2; molecular weight 356.51 g/mol.

Mechanism & targets

Molecular targets (2)

Target	Gene	Action	Activity
Beta-2 adrenergic receptor	ADRB2	unknown	—
D(1A) dopamine receptor	DRD1	unknown	—

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1989-01-01	YEAR INTRODUCED	—	—

ATC classification

ATC code	Therapeutic hierarchy
C01CA14	CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES › Adrenergic and dopaminergic agents

Chemical structure

• Molecular formula: C₂₂H₃₂N₂O₂
• Molecular weight: 356.51 g/mol
• CAS number: —
• InChIKey: RYBJORHCUPVNMB-UHFFFAOYSA-N
• PubChem CID: 55483

OC1=C(O)C=C(CCNCCCCCCNCCC2=CC=CC=C2)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Dopexamine work?

Its molecular targets in DrugCentral include ADRB2 and DRD1.

When was Dopexamine first approved?

Dopexamine was first approved by the YEAR INTRODUCED in 1989.

What is the chemical formula of Dopexamine?

Dopexamine has the molecular formula C22H32N2O2 and a molecular weight of 356.51 g/mol.

Sources

• DrugCentral drug card 948 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL77622 — compound record and bioactivity
• PubChem CID 55483 — chemical identifiers
• DrugBank DB12313 — drug record
• FDA UNII 398E7Z7JB5 — substance identity
• UniProt P07550 (ADRB2) — target protein
• UniProt P21728 (DRD1) — target protein

How this page is built: methodology · editorial policy & corrections.